
Amryt Pharma Holdings Ltd
LSE:AMYT

Fundamental Analysis


Revenue & Expenses Breakdown
Amryt Pharma Holdings Ltd
Balance Sheet Decomposition
Amryt Pharma Holdings Ltd
Current Assets | 276.8m |
Cash & Short-Term Investments | 123.2m |
Receivables | 52.8m |
Other Current Assets | 100.8m |
Non-Current Assets | 578.7m |
PP&E | 8.4m |
Intangibles | 488.7m |
Other Non-Current Assets | 81.5m |
Free Cash Flow Analysis
Amryt Pharma Holdings Ltd
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Amryt Pharma Holdings Ltd
Revenue
|
210.2m
USD
|
Cost of Revenue
|
-106.8m
USD
|
Gross Profit
|
103.4m
USD
|
Operating Expenses
|
-126.8m
USD
|
Operating Income
|
-23.3m
USD
|
Other Expenses
|
-64.2m
USD
|
Net Income
|
-87.5m
USD
|
AMYT Profitability Score
Profitability Due Diligence
Amryt Pharma Holdings Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Score
Amryt Pharma Holdings Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
AMYT Solvency Score
Solvency Due Diligence
Amryt Pharma Holdings Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Score
Amryt Pharma Holdings Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AMYT Price Targets Summary
Amryt Pharma Holdings Ltd
Dividends
Current shareholder yield for AMYT is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?